AstraZeneca set up a globetrotting supply network for its COVID-19 vaccine to deliver doses around the world, but it hasn't tapped regional producers to ease de...

Despite the ever-growing use of targeted oncology drugs, chemotherapy is still widely used in lung cancer—and it still comes with potentially severe side effect...

Sanofi and Bristol Myers Squibb have spent years battling Plavix litigation—including state-level claims that the drugmakers didn’t adequately warn about the blood t...

Bluebird Bio’s blood disease gene therapy Zynteglo simply can’t catch a break, even now that it’s cleared for the market. Tuesday, the Massachusetts biotech s...

Novartis' heart failure drug Entresto has been on the ascent after a slower-than-expected debut on the market, and now the drug has an expanded FDA label that could ...

Diagnosing patients via telehealth calls can be challenging, but especially when it comes to movement disorders. For Neurocrine Biosciences, that discovery was ...

When Bristol Myers Squibb and Exelixis first unveiled kidney cancer data for the combination of Opdivo and Cabometyx last fall, industry watchers couldn’t determine ...

In the global COVID-19 vaccine race, mRNA vaccines quickly got out to the front of the pack and two reached distribution in less than a year. But their quick success...

More than half the U.S. population lives with chronic disease, according to the Centers for Disease Control and Prevention. Patients cycle in and out of hospitals, s...

Switzerland's Lonza last month said it had whittled down a shortlist of bidders for its specialty ingredients business. Now, with buyers in place, the CDMO is i...